Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

Abstract

MUTATIONS in the genes encoding amyloid-β precursor protein (APP)1 presenilin 1 (PS1)2 and presenilin 2 (PS2)3,4 are known to cause early-onset, autosomal dominant Alzheimer's disease. Studies of plasma and fibroblasts from subjects with these mutations have established that they all alter amyloid β-protein (βAPP) processing, which normally leads to the secretion of amyloid-β protein (relative molecular mass 4,000; Mr 4K; 90% Aβ1–40, 10% Aβ1–42(43)), so that the extracellular concentration of Aβ42(43) is increased5. This increase in Aβ42(43) is believed to be the critical change that initiates Alzheimer's disease pathogenesis because Aβ42(43) is deposited early and selectively in the senile plaques that are observed in the brains of patients with all forms of the disease. To establish that the presenilin mutations increase the amount of Aβ42(43) in the brain and to test whether presenilin mutations act as true (gain of function) dominants, we have now constructed mice expressing wild-type and mutant presenilin genes. Analysis of these mice showed that overexpression of mutant, but not wild-type, PS1 selectively increases brain Aβ42(43). These results indicate that the presenilin mutations probably cause Alzheimer's disease through a gain of deleterious function that increases the amount of Aβ42(43) in the brain.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Goate, A. et al. Nature 349, 704–706 (1991).

    Article  ADS  CAS  Google Scholar 

  2. Sherrington, R. et al. Nature 375, 754–760 (1995).

    Article  ADS  CAS  Google Scholar 

  3. Levy-Lahad, E. et al. Science 269, 973–977 (1995).

    Article  ADS  CAS  Google Scholar 

  4. Rogaev, E. et al. Nature 376, 775–778 (1995).

    Article  ADS  CAS  Google Scholar 

  5. Suzuki, N. et al. Science 264, 1335–1340 (1994).

    ADS  Google Scholar 

  6. Alzheimer's Disease Collaborative Group Nature Genet. 11, 219–222 (1995).

  7. Haltia, M. et al. Ann. Neurol. 36, 362–367 (1994).

    Article  CAS  Google Scholar 

  8. Thinakaran, G. et al. Neuron 17, 181–190 (1996).

    Article  CAS  Google Scholar 

  9. Iwatsubo, T. et al. Ann. Neurol. 37, 294–299 (1995).

    Article  CAS  Google Scholar 

  10. Gravina, S. A. et al. J. Biol. Chem. 270, 7013–7016 (1995).

    Article  CAS  Google Scholar 

  11. Games, D. Nature 373, 523–527 (1995).

    Article  ADS  CAS  Google Scholar 

  12. Hsiao, K. et al. Science (in the press).

  13. Scheuner, D. et al. Nature Med. 2, 864–870 (1996).

    Article  CAS  Google Scholar 

  14. Kovacs, D. M. et al. Nature Med. 2, 224–229 (1996).

    Article  CAS  Google Scholar 

  15. Levitan, D. & Greewald, I. Nature 377, 351–354 (1996).

    Article  ADS  Google Scholar 

  16. L'Hernault, S. W. & Arduengo, P. M. J. Cell Biol. 119, 55–68 (1992).

    Article  CAS  Google Scholar 

  17. Xu, H., Greengard, P. & Gandy, S. J. Biol. Chem. 270, 23243–23245 (1995).

    Article  CAS  Google Scholar 

  18. Sasahara, M. et al. Cell 64, 217–227 (1991).

    Article  CAS  Google Scholar 

  19. Brinster, R. et al. Proc. Natl Acad. Sci. USA 85, 836–840 (1988).

    Article  ADS  CAS  Google Scholar 

  20. Suzuki, N. et al. Am. J. Path. 145, 452–460 (1994).

    CAS  PubMed  Google Scholar 

  21. Odaka, N. et al. Biochemistry 34, 10272–10278 (1995).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duff, K., Eckman, C., Zehr, C. et al. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713 (1996). https://doi.org/10.1038/383710a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/383710a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing